Both in Pharmaceuticals
Savara vs Alto Neuroscience
Over the past year SVRA returned +44.3% and ANRO returned +562.8%; their daily moves had a correlation of 0.28.
SVRA +44.3% ANRO +562.8%Growth of $1, one year, split-adjusted
| Metric | SVRA | ANRO |
|---|---|---|
| Price | $5.08 | $26.58 |
| Market cap | $1.04B | $1.04B |
| Today | +0.20% | −0.30% |
| 1 month | −3.4% | −24.3% |
| 6 months | +0.6% | +33.0% |
| Year to date | −15.8% | +49.3% |
| 1 year | +44.3% | +572.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $142.9M | $225.1M |
| Dividend yield | — | — |
| Volatility (60d) | 44.0% | 55.6% |
| Short % of float | 30.2% | 16.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).